Ayurvedic management of recurrent unilateral central serous retinopathy with neurosensory detachment: A case report
DOI:
https://doi.org/10.47552/ijam.v16i4.6190Keywords:
Ayurveda, Case report, Central serous retinopathy, Neuro sensory detachment, Netra Basti, PanchakarmaAbstract
Central Serous Retinopathy (CSR) is a retinal disorder caused by subretinal fluid accumulation leading to serous detachment of the neurosensory retina, often involving the macular region. It usually presents with sudden, painless visual impairment, image distortion, and central scotoma. Major predisposing factors include psychological stress, hypertension, prolonged corticosteroid use, and a type A personality. Conventional therapy such as anti‑VEGF injections, laser photocoagulation, or observation primarily offers symptomatic relief but does not prevent recurrence and may risk retinal damage. In Ayurvedic context, CSR resembles Sannipatika Timir described under Drishtipatalagata Rogas, caused by vitiation of Tridosha affecting the inner ocular layers. A 43‑year‑old male presented with blurred and double vision, central dark spot, insomnia, constipation, and stress for 25 days and was diagnosed with CSR in the left eye. He underwent Panchakarma therapy including Netra Basti and Shirodhara, along with internal medicines—Punarnavadi Kashaya, Gandharvahasthadi Kashaya, and Chandraprabha Vati for 20 days. Following treatment, vision improved from 6/12 to 6/6 with complete resolution of macular edema confirmed on optical coherence tomography. One‑year follow‑up showed no recurrence. The case highlights the potential of Ayurvedic management in promoting retinal recovery and preventing CSR relapse naturally.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 International Journal of Ayurvedic Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.

